Digestives & Intestinal Remedies - Taiwan

  • Taiwan
  • In Taiwan, the revenue generated in the Digestives & Intestinal Remedies market market in 2024 amounts to US$279.90m.
  • It is projected that the market will experience an annual growth rate of 3.94% (CAGR 2024-2029).
  • In comparison to other countries, in China leads the global market with a revenue of US$4,408.00m in 2024.
  • When considering the total population, the per person revenue in Taiwan is US$11.68 in 2024.
  • Taiwan is experiencing a growing demand for natural and herbal-based digestive and intestinal remedies in the OTC Pharmaceuticals market.

Key regions: Canada, United States, Australia, Brazil, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in Taiwan is experiencing steady growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.Customer preferences in Taiwan are shifting towards a more health-conscious lifestyle, leading to an increased demand for digestive and intestinal remedies. As people become more aware of the importance of gut health, they are seeking products that can alleviate digestive issues and promote overall well-being. This trend is not unique to Taiwan, as it is also observed in other countries worldwide.Trends in the market indicate a growing interest in natural and herbal remedies for digestive problems. Consumers are increasingly opting for products that are made from natural ingredients and have minimal side effects. This has led to the rise of herbal supplements and probiotics in the Digestives & Intestinal Remedies market in Taiwan. Manufacturers are responding to this trend by introducing new products that cater to these preferences.Local special circumstances in Taiwan also contribute to the development of the Digestives & Intestinal Remedies market. The Taiwanese population has a high prevalence of digestive disorders, such as irritable bowel syndrome and acid reflux. This creates a significant market opportunity for companies offering products that can alleviate these conditions. Additionally, the aging population in Taiwan is more prone to digestive issues, further driving the demand for digestive and intestinal remedies.Underlying macroeconomic factors also play a role in the growth of the Digestives & Intestinal Remedies market in Taiwan. The country has a strong healthcare system and a high level of disposable income, allowing consumers to afford and access these products. Furthermore, the government in Taiwan has been actively promoting health and wellness, leading to increased awareness and demand for digestive and intestinal remedies.In conclusion, the Digestives & Intestinal Remedies market in Taiwan is experiencing growth driven by changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. As consumers become more health-conscious and seek natural remedies, the market is responding with innovative products. The high prevalence of digestive disorders and the aging population in Taiwan further contribute to the market's growth. With a strong healthcare system and government support for health and wellness, the Digestives & Intestinal Remedies market in Taiwan is expected to continue its upward trajectory.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)